Sigma Healthcare Limited
SIG.AXHealthcareASXMedical Distribution · Last scanned May 29, 2026
Scan Results
Daily timeframeSigma Healthcare Limited operates as a retail pharmacy franchisor and pharmaceutical wholesale and distributor to community pharmacies primarily in Australia. At a $33.77B market cap, Sigma Healthcare Limited ranks as a large-cap company within healthcare. It offers support services to a network of franchised retail pharmacies; third and fourth party logistics services to pharmaceutical manufacturers and other supplier partners; and health services.
Market Cap
$33.77B
Beta
0.33
P/E (TTM)
58.50
P/E (Fwd)
38.17
EPS (TTM)
$0.05
EPS (Fwd)
$0.08
ROE
—
ROA
—
Cash
$160.5M
Total Debt
$2.00B
Free CF
—
52W Change
-8.3%
Annual Financials
Cash vs Debt
Sigma Healthcare Limited carries $2.00B in total debt against $160.5M in cash reserves — debt is roughly 12.5x the cash position. Managing this leverage effectively will be important for long-term financial stability. Revenue has grown from $3.66B (2023) to $6.00B (2025), reflecting a 64% increase over the period.
The relatively low beta of 0.33 suggests SIG.AX is a less volatile holding compared to the broader index. Sigma Healthcare Limited carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. At over 50x earnings, SIG.AX carries valuation risk — any slowdown in growth expectations could lead to meaningful price adjustments. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Sigma Healthcare Limited and its sector.